Goodwill, non-deductible
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $16.90B | $17.10B | $16.80B | $16.90B | $17.30B | $17.40B | $17.40B | $17.30B |
| Diagnostic Products | $3.50B | $3.60B | $3.50B | $3.50B | $3.60B | $3.60B | $3.60B | $14.90B |
| Established Pharmaceuticals | $2.60B | $2.70B | $2.60B | $2.60B | $2.70B | $2.70B | $2.70B | $2.70B |
| Nutritional Products | $285.00M | $285.00M | $285.00M | $285.00M | $285.00M | $285.00M | $285.00M | $300.00M |
| Total | $23.31B | $23.66B | $23.11B | $23.36B | $23.95B | $23.97B | $24.04B | $35.22B |
Segments
Established PharmaceuticalsView metric
Nutritional ProductsView metric
Diagnostic ProductsView metric
Medical DevicesView metric